acetylcysteine and Scleroderma, Systemic

acetylcysteine has been researched along with Scleroderma, Systemic in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19902 (16.67)18.7374
1990's0 (0.00)18.2507
2000's6 (50.00)29.6817
2010's2 (16.67)24.3611
2020's2 (16.67)2.80

Authors

AuthorsStudies
Khodamoradi, Z; Mehrabi, S; Moradi, MM; Nazarinia, MA1
Kim, KJ; Moon, SJ; Park, KS; Tagkopoulos, I1
Borghese, F; Pisarri, S; Rosato, E; Salsano, F1
Amoroso, A; Barbano, B; Cianci, R; Gigante, A; Menghi, G; Pisarri, S; Rosato, E; Rossi, C; Salsano, F; Zardi, EM1
Jimenez, SA; Kendzicky, A; Koch, AE; Phillips, K; Piera-Velazquez, S; Pinney, AJ; Seibold, JR; Talia, NN; Tsou, PS1
Lota, HK; Wells, AU1
D'Alfonso, C; Failli, P; Generini, S; Giovannelli, L; Matucci-Cerinic, M; Orsi, S; Palmieri, L; Pignone, A; Rosso, AD; Stanflin, N; Zilletti, L1
Chizzolini, C; Dayer, JM; Fineschi, S; Guerne, PA; Reith, W1
Amico, D; Gabrielli, A; Giacomelli, R; Matucci-Cerinic, M; Salsano, F; Sambo, P; Valentini, G1
Baroni, SS; Dusi, S; Gabrielli, A; Luchetti, M; Orlandini, G; Paroncini, P; Sambo, P1
Clements, PJ; Furst, DE; Harris, R; Levy, J; Paulus, HE; Ross, M1
Bianchi, V; Ghirardo, G; Rovetta, G1

Reviews

1 review(s) available for acetylcysteine and Scleroderma, Systemic

ArticleYear
The evolving pharmacotherapy of pulmonary fibrosis.
    Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:1

    Topics: Acetylcysteine; Anti-Inflammatory Agents, Non-Steroidal; Humans; Idiopathic Interstitial Pneumonias; Immunosuppressive Agents; Indoles; Lung Diseases, Interstitial; Pulmonary Fibrosis; Pyridones; Randomized Controlled Trials as Topic; Sarcoidosis, Pulmonary; Scleroderma, Systemic; Treatment Outcome

2013

Trials

4 trial(s) available for acetylcysteine and Scleroderma, Systemic

ArticleYear
Effects of N-acetylcysteine on Pulmonary Functions in Patients with Systemic Sclerosis: A Randomized Double Blind, Placebo Controlled Study.
    Current rheumatology reviews, 2020, Volume: 16, Issue:2

    Topics: Acetylcysteine; Adult; Double-Blind Method; Female; Free Radical Scavengers; Humans; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Respiratory Function Tests; Scleroderma, Systemic; Treatment Outcome; Young Adult

2020
N-acetylcysteine infusion reduces the resistance index of renal artery in the early stage of systemic sclerosis.
    Acta pharmacologica Sinica, 2009, Volume: 30, Issue:9

    Topics: Acetylcysteine; Female; Free Radical Scavengers; Humans; Male; Microscopic Angioscopy; Middle Aged; Renal Artery; Renal Artery Obstruction; Scleroderma, Systemic; Vascular Resistance

2009
Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study.
    The Journal of rheumatology, 2001, Volume: 28, Issue:10

    Topics: Acetylcysteine; Adult; Cold Temperature; Female; Follow-Up Studies; Free Radical Scavengers; Humans; Injections, Intravenous; Male; Middle Aged; Oxidative Stress; Pilot Projects; Plethysmography; Raynaud Disease; Scleroderma, Systemic; Skin Ulcer; Treatment Outcome

2001
Measurement of clinical change in progressive systemic sclerosis: a 1 year double-blind placebo-controlled trial of N-acetylcysteine.
    Annals of the rheumatic diseases, 1979, Volume: 38, Issue:4

    Topics: Acetylcysteine; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Prospective Studies; Scleroderma, Systemic; Skin; Time Factors

1979

Other Studies

7 other study(ies) available for acetylcysteine and Scleroderma, Systemic

ArticleYear
Network-based modeling of drug effects on disease module in systemic sclerosis.
    Scientific reports, 2020, 08-07, Volume: 10, Issue:1

    Topics: Acetylcysteine; Dasatinib; Drug Repositioning; Female; Fibrosis; Genome-Wide Association Study; Humans; Imatinib Mesylate; Indoles; Male; Molecular Targeted Therapy; Protein Kinase Inhibitors; Scleroderma, Systemic; Signal Transduction

2020
The treatment with N-acetylcysteine of Raynaud's phenomenon and ischemic ulcers therapy in sclerodermic patients: a prospective observational study of 50 patients.
    Clinical rheumatology, 2009, Volume: 28, Issue:12

    Topics: Acetylcysteine; Female; Fingers; Free Radical Scavengers; Humans; Infusions, Intravenous; Ischemia; Male; Middle Aged; Raynaud Disease; Scleroderma, Systemic; Skin; Skin Ulcer; Treatment Outcome

2009
Effect of oxidative stress on protein tyrosine phosphatase 1B in scleroderma dermal fibroblasts.
    Arthritis and rheumatism, 2012, Volume: 64, Issue:6

    Topics: Acetylcysteine; Cells, Cultured; Collagen Type I; Fibroblasts; Free Radical Scavengers; Humans; Oxidative Stress; Phosphorylation; Platelet-Derived Growth Factor; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Reactive Oxygen Species; Receptors, Platelet-Derived Growth Factor; Scleroderma, Systemic; Skin; Superoxides

2012
Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis.
    Nitric oxide : biology and chemistry, 2002, Volume: 7, Issue:4

    Topics: Acetylcysteine; Bronchoalveolar Lavage Fluid; Female; Humans; Immunohistochemistry; Lung; Macrophages, Alveolar; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Scleroderma, Systemic; Superoxides

2002
Proteasome blockade exerts an antifibrotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and up-regulating metalloproteinase-1 production in human dermal fibroblasts.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2006, Volume: 20, Issue:3

    Topics: Acetylcysteine; Anthracenes; Boronic Acids; Bortezomib; Collagen Type I; Dose-Response Relationship, Drug; Down-Regulation; Extracellular Matrix; Fibroblasts; Fibrosis; Genes, jun; Humans; JNK Mitogen-Activated Protein Kinases; Leupeptins; Matrix Metalloproteinase 1; Phosphorylation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-jun; Pyrazines; RNA Polymerase II; RNA, Messenger; Scleroderma, Systemic; Skin; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta; Up-Regulation

2006
Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway.
    Arthritis and rheumatism, 2001, Volume: 44, Issue:11

    Topics: Acetylcysteine; Allopurinol; alpha-Tocopherol; Biphenyl Compounds; Cell Division; Cells, Cultured; Cytokines; Dose-Response Relationship, Drug; Fibroblasts; Growth Substances; Humans; Hydrogen Peroxide; Microscopy, Confocal; NADPH Oxidases; Onium Compounds; Oxidative Stress; Phenotype; Phosphoproteins; Protein Transport; Reactive Oxygen Species; Rotenone; Scleroderma, Localized; Scleroderma, Systemic; Skin; Up-Regulation

2001
[The action of sulfhydryl substances in fibrosis in joint pathology].
    Minerva medica, 1971, Sep-05, Volume: 62, Issue:66

    Topics: Acetylcysteine; Cysteamine; Dupuytren Contracture; Humans; Joint Diseases; Scleroderma, Systemic; Sulfhydryl Compounds

1971